Peptides and Sports Doping: How WADA Treats Peptide Hormones and Secretagogues

If you follow peptide research, you have probably noticed how often the same compounds show up in anti-doping headlines. Growth hormone secretagogues, IGF-1, EPO-adjacent agents, and a long tail of "research" peptides all sit somewhere on the World Anti-Doping Agency (WADA) Prohibited List. This article maps how that list is organized, why so many peptides land on it, and what "prohibited at all times" actually means. It is educational reference material, not medical or legal advice.

Research log: what we checked

We worked from WADA's own category structure and from anti-doping bodies (USADA, the Athletics Integrity Unit) plus published detection literature, cross-referencing the S0 and S2 definitions against the substance examples WADA lists. Where a claim is specific — a category number, a named compound — it traces back to those sources. Regulatory lists change every January, so always confirm current status against a primary source such as GlobalDRO or the live WADA list before relying on anything here.

The two categories that matter for peptides

Most peptides an athlete might encounter fall into one of two buckets on the Prohibited List: S0 (Non-Approved Substances) and S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics). Both are prohibited at all times — in-competition and out-of-competition alike. There is no off-season window and, for these classes, no automatic Therapeutic Use Exemption.

S2: named peptide hormones and growth factors

S2 is the category built specifically around hormones. It is subdivided, and the structure is worth knowing:

A crucial detail: WADA's naming is illustrative, not exhaustive. The category prohibits substances "with a similar chemical structure or similar biological effect(s)." Any compound that drives pulsatile GH release through the ghrelin or GHRH receptor can fall under S2 even if it is not printed by name. You can read more about the underlying molecules in our peptide library.

S0: the catch-all for "non-approved" substances

S0 exists to cover everything the named sections do not. WADA defines it as any pharmacological substance not addressed elsewhere on the list and with no current approval by any governmental regulatory health authority for human therapeutic use — including drugs in pre-clinical or clinical development, discontinued or designer compounds, and substances approved only for veterinary use.

This is where the majority of so-called research peptides live. BPC-157 is the textbook example: WADA added it to the Prohibited List under S0 in 2022 because it has never gained regulatory approval for human use and has no completed Phase III human trial data. USADA's guidance is blunt — athletes should "never use a product that is marketed for 'research only'." Because these substances are unapproved, they are also generally not eligible for a Therapeutic Use Exemption. If you want to check whether a given peptide has any approval at all, our FDA status reference is a starting point.

How these substances are tested

Detection is not one method but several. Small synthetic peptides and secretagogues are typically screened by liquid chromatography–high-resolution mass spectrometry (LC-HRMS/MS), which can identify parent compounds and their metabolites in urine or blood. EPO and blood-boosting agents are pursued differently — through direct analytical methods and, indirectly, through the Athlete Biological Passport, which tracks an athlete's own blood markers over time and flags physiologically improbable changes rather than the drug itself. Growth hormone abuse is targeted with dedicated GH isoform and biomarker tests. The practical takeaway: "undetectable" is a marketing claim, not a scientific one, and detection windows keep expanding.

Why this matters even outside elite sport

Many masters-level, collegiate, and drug-tested federation athletes are bound by WADA-aligned rules without realizing how broad S0 is. A peptide bought as a "research chemical" is not exempt just because it is unregulated — being unregulated is precisely what places it in S0. Strict liability means the athlete is responsible for whatever is in their system, regardless of intent or of what a label claimed.

For anyone logging or studying these compounds, the honest summary is short: if a peptide acts like a hormone or growth factor, it is almost certainly S2; if it lacks human regulatory approval, it is almost certainly S0; and either way, it is banned at all times for tested athletes.

PepStash is a research log and reference tool. This article is educational and is not medical advice — it does not diagnose, treat, or recommend any protocol. Regulatory status and trial data change; always verify against primary sources and consult a licensed physician before making any decisions about your health.